The need for thorough phase II studies in medicines development for Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1186/s13195-015-0153-y
Published Online: 2015-10-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gray, Julian A.
Fleet, David
Winblad, Bengt
Text and Data Mining valid from 2015-10-26
Version of Record valid from 2015-10-26
Article History
First Online: 26 October 2015